ACCENDRA HEALTH INC/VA/ (ACH): Entry into a Material Definitive Agreement
ACCENDRA HEALTH INC/VA/ (ACH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 6 d100115dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 AMENDMENT NO. 4 TO CREDIT AGREEMENT AND CONSENT AMENDMENT NO. 4 TO CREDIT AGREEMENT AND CONSENT, dated as of June 15, 2026 (this “ Amendment ”), by and among ACCENDRA HEALTH, INC. (f/k/a OWENS & MINOR, INC.), a Virginia cor
How this was made
The 30-second read
Why it matters
The company’s revolving credit facility is being amended with new intercreditor agreements (first- and second-lien) and a revolving credit commitment structure of $300,000,000 for the amendment facility, which can change financing flexibility and secured-debt dynamics.
Market read
Material credit-facility amendment disclosure can move perceived liquidity/credit risk, especially for leveraged healthcare service issuers.
What to watch
Traders should focus on the omitted Exhibit A/B/C/D/E/F terms (covenants, pricing, maturity, collateral package) to gauge whether risk increased or decreased.
Background
The filing is an SEC Form 8-K for Accendra Health (ACH) describing entry into a material definitive agreement: Amendment No. 4 to its credit agreement and related consent amendments.
Ticker impact
Accendra Health entered Amendment No. 4 to its credit agreement, expanding/reshaping revolving credit commitments and intercreditor arrangements.
Likely modest near-term credit-spread/liquidity sensitivity; equity reaction depends on covenant/terms details not shown in the excerpt.
Form 8-K Item 1.01/2.03 plus a $300M revolving commitment request indicates a meaningful balance-sheet/financing update, but the excerpt lacks the specific economic terms and covenant changes.
Market effects
Credit-facility amendments in healthcare services can signal refinancing needs or lender appetite, influencing sector financing risk premia.
No clear regional read-through beyond US healthcare financing markets.
Limited; this is primarily US bank-lending and capital-structure news.
Counterpoint
The amendment may be largely administrative (intercreditor/structure) rather than a true economic repricing, limiting equity impact.
Key entities
- issuerAccendra Health, Inc. (f/k/a Owens & Minor, Inc.)
Borrower entering Amendment No. 4 to its credit agreement; subject of the 8-K.
- lender_agentBank of America, N.A.
Administrative and collateral agent; also a party to the amendment as administrative/collateral agent and lender-related capacity.
- loan_partiesBarista Acquisition I, LLC; Barista Acquisition II, LLC; Byram Healthcare Centers, Inc.; Apria, Inc.
Borrowers/loan parties named in the amendment agreement.
